Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 189301 - 189320 out of 485383 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Germany (D) | (L01FG02) ramucirumab | CYRAMZA 10 mg/ml Konz.z.Herst.e.Infusionslösung | 10 Milliliter, status: Rx, sales: im Vertrieb, import: nein, Klinikpackung | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms | Lilly |
| Germany (D) | (L01FX04) ipilimumab | YERVOY 5 mg/ml Konz.z.Herst.e.Inf.-Lsg.Dsfl.200mg | 40 Milliliter, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Melanoma; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Mesothelioma, Malignant; Colorectal Neoplasms | Bristol-MyersSquibb |
| Germany (D) | (L01FX04) ipilimumab | YERVOY 5 mg/ml Konz.z.Herst.e.Inf.-Lsg.Dsfl.50mg | 10 Milliliter, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Melanoma; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Mesothelioma, Malignant; Colorectal Neoplasms | Bristol-MyersSquibb |
| Germany (D) | (L01FX06) dinutuximab beta | QARZIBA 4,5 mg/ml 20mg Konz.z.Her.e.Inf.-Lsg.Dsfl. | 1X4.5 Milliliter, status: Rx, sales: im Vertrieb, import: nein, Klinikpackung | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuroblastoma | Recordati(Schiphol-Rijk) |
| Germany (D) | (L01FX07) blinatumomab | BLINCYTO 38,5 mug Plv.f.e.Konz.u.Lsg.z.H.e.Inf.Lsg | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | Amgen |
| Germany (D) | (L01FX09) mogamulizumab | POTELIGEO 4 mg/ml 20mg Konz.z.H.Inf.-Lösung Dsfl. | 5 Milliliter, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Sezary Syndrome; Mycosis Fungoides | Kyowa |
| Germany (D) | (L01FX12) tafasitamab | MINJUVI 200 mg Plv.f.e.Konz.z.H.e.Inf.-Lsg. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | Incyte |
| Germany (D) | (L01FX13) enfortumab vedotin | PADCEV 20 mg Plv.f.e.Konz.z.H.e.Inf.-Lsg. | 1 Stück, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Urologic Neoplasms | Astellas |
| Germany (D) | (L01FX13) enfortumab vedotin | PADCEV 30 mg Plv.f.e.Konz.z.H.e.Inf.-Lsg. | 1 Stück, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Urologic Neoplasms | Astellas |
| Germany (D) | (L01FX14) polatuzumab vedotin | POLIVY 140 mg Plv.z.Her.e.Inf.-Lösungskonz.Dsfl. | N2, 1 Stück, status: Rx, sales: außer Vertrieb, import: ja, Org. PZN: 15253787, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | CCPharma |
| Germany (D) | (L01FX14) polatuzumab vedotin | POLIVY 140 mg Plv.z.Her.e.Inf.-Lösungskonz.Dsfl. | N2, 1 Stück, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | Roche |
| Germany (D) | (L01FX14) polatuzumab vedotin | POLIVY 140 mg Plv.z.Her.e.Inf.-Lösungskonz.Dsfl. | N2, 1 Stück, status: Rx, sales: außer Vertrieb, import: ja, Org. PZN: 15253787, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | Abacus |
| Germany (D) | (L01FX14) polatuzumab vedotin | POLIVY 30 mg Plv.z.Her.e.Inf.-Lösungskonz.Dsfl. | 1 Stück, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | Roche |
| Germany (D) | (L01FX17) sacituzumab govitecan | TRODELVY 200 mg Plv.f.e.Konz.z.H.e.Inf.-Lsg.Dsfl. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Triple Negative Breast Neoplasms | Gilead |
| Germany (D) | (L01FX20) tremelimumab | IMJUDO 20 mg/ml Konz.z.Her.e.Infusionslösung 25mg | N1, 1.25 Milliliter, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular | AstraZenecaSpezialvertieb |
| Germany (D) | (L01FX20) tremelimumab | IMJUDO 20 mg/ml Konz.z.Her.e.Infusionslösung 300mg | N1, 15 Milliliter, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular | AstraZenecaSpezialvertieb |
| Germany (D) | (L01FX22) loncastuximab tesirine | ZYNLONTA 10 mg Plv.f.e.Konz.z.H.e.Inf.-Lsg.Dsfl. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse; Lymphoma, B-Cell | SwedishOrphanBiovitrum |
| Germany (D) | (L01FX24) teclistamab | TECVAYLI 10 mg/ml Injektionslösung Dsfl.30 mg | N1, 1X3 Milliliter, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAG |
| Germany (D) | (L01FX24) teclistamab | TECVAYLI 90 mg/ml Injektionslösung Dsfl.153 mg | N1, 1X1.7 Milliliter, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAG |
| Germany (D) | (L01FX25) mosunetuzumab | LUNSUMIO 1 mg Konz.z.Herst.einer Infusionslösung | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | Roche |
Pages
